Acute Graft Versus Host Disease Grade II-IV
2 clinical trials · Condition
◉ Watch Acute Graft Versus Host Disease Grade II-IV
| Record | Firm | Date |
|---|---|---|
| Study of Gecacitinib in the Treatment of Acute Graft-Versus-Host Disease After Failure of Ruxolitinib-containing Second-line Therapy (NCT07197112) | Ruijin Hospital | 2025-10-01 |
| Pharmacokinetics of Micafungin Given Twice Weekly Intravenously Compared to Micafungin Given Daily to Patients at Risk for Developing an Invasive Fungal Disease (NCT02172768) | Radboud University Medical Center | 2014-10-01 |
Track Acute Graft Versus Host Disease Grade II-IV automatically
Every clearance here is in the API, with alerts when new ones post.